A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2014
At a glance
- Drugs ARRY 403 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacogenomic; Therapeutic Use
- 08 Aug 2013 Results from this trial are now available and will be shared in the future, according to an Array BioPharma media release.
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2012-001382-32).